SL
TMO icon

Summitry LLC’s Thermo Fisher Scientific TMO Stock Holding History

Summitry LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68M Sell
135,659
-3,591
-3% -$1.72M 2.24% 12
2026
Q1 		$68.4M Sell
139,250
-1,238
-0.9% -$672K 2.41% 13
2025
Q4 		$81.4M Sell
140,488
-971
-0.7% -$549K 3.39% 9
2025
Q3 		$68.6M Buy
141,459
+2,941
+2% +$1.37M 2.9% 11
2025
Q2 		$56.2M Buy
+138,518
New +$57.9M 2.54% 16

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Summitry LLC's TMO Position: Q2 2026 in Review

Summitry LLC reduced its Thermo Fisher Scientific (TMO) stake by 2.6% in Q2 2026, selling an estimated $1.72M and leaving 135,659 shares worth $68M. The position accounts for 2.24% of the portfolio, ranked #12.

Summitry LLC first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. The position peaked at $81.4M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Summitry LLC held 135,659 shares of Thermo Fisher Scientific worth $68M as of Q2 2026.
  • Summitry LLC sold 3,591 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.72M.
  • Thermo Fisher Scientific made up 2.24% of Summitry LLC's portfolio in Q2 2026, its #12 holding.
  • Summitry LLC first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • Summitry LLC's Thermo Fisher Scientific position peaked at $81.4M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.